SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-21-008845
Filing Date
2021-08-12
Accepted
2021-08-12 16:16:24
Documents
64
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT vtgn_10q.htm   iXBRL 10-Q 1162809
2 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF vtgn_ex311.htm EX-31.1 9745
3 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF vtgn_ex312.htm EX-31.2 10029
4 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE vtgn_ex32.htm EX-32 4591
  Complete submission text file 0001654954-21-008845.txt   4800843

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA vtgn-20210630.xsd EX-101.SCH 45320
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vtgn-20210630_cal.xml EX-101.CAL 41686
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vtgn-20210630_def.xml EX-101.DEF 153646
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtgn-20210630_lab.xml EX-101.LAB 272827
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtgn-20210630_pre.xml EX-101.PRE 236336
10 EXTRACTED XBRL INSTANCE DOCUMENT vtgn_10q_htm.xml XML 739461
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-37761 | Film No.: 211167772
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences